<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01617304</url>
  </required_header>
  <id_info>
    <org_study_id>M201</org_study_id>
    <nct_id>NCT01617304</nct_id>
  </id_info>
  <brief_title>Effects of Food Cooking on Diabetes-2 Risk Factors</brief_title>
  <acronym>Age-2</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Ministry of Science, Technology and Innovation, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the project is to investigate the effects of advanced glycation end products
      (AGEs) formed in food during the cooking process as well as AGEs formed naturally in the
      human body, on insulin sensitivity and risk factors for type 2 diabetes. The hypothesis is
      that i) food content of AGEs is lower using boiling and steaming cooking methods and that ii)
      AGEs formation in the body is lower at low dietary intake of certain sugar forms.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in HOMA from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
    <description>insulin sensitivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in OGTT from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks at 0 and 120 min</time_frame>
    <description>insulin sensitivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in appetite hormones (leptin, adiponectin, GLP-1, glukagon, ghrelin) from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in plasma and urin AGEs from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in immune response (CRP, C-peptide, IL-1B, IL-6, VCAM, ICAM, MIF, TNF-a, buffycoat) from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in metabolomics dats from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in AGE levels in skin from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in lipid profile (TG, Chol, LDL, HDL, ox LDL, glycated LDL, fattyacids)from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in HbA1c from baseline to 4 weeks</measure>
    <time_frame>0 and 4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obesity</condition>
  <condition>Type 2 Diabetes</condition>
  <condition>Insulin Resistance</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>low AGE, glucose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Food prepared by boiling/steaming and 20 g of glucose 3 times a day in a water solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low AGE, fructose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Food prepared by boiling/steaming and 20 g of fructose 3 times a day in a water solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high AGE, fructose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Food prepared by frying/baking and 20 g of fructose 3 times a day in a water solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high AGE, glucose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Food prepared by frying/baking and 20 g of glucose 3 times a day in a water solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary intervention</intervention_name>
    <description>Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution</description>
    <arm_group_label>low AGE, glucose</arm_group_label>
    <arm_group_label>low AGE, fructose</arm_group_label>
    <arm_group_label>high AGE, fructose</arm_group_label>
    <arm_group_label>high AGE, glucose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women, healthy between 20 and 50 y

          -  BMI between 25 and 40 kg/m2

          -  weight circumference over 88 cm

        Exclusion Criteria:

          -  weigh changes within the last 2 months more than +/- 3 kg

          -  Physical activity more than 8 h per week

          -  smoking

          -  medications and supplements

          -  being vegetarian or vegan

          -  pregnancy or breast feeding

          -  postmenopause

          -  chronic disease

          -  previous gastric bypass surgery

          -  blood donation within the last 3 months

          -  Involvement in other clinical trials

          -  allergic to paraaminobenzoic acid
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne G Bugel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Human Nutrition, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Human Nutrition, University of Copenhagen</name>
      <address>
        <city>Frederiksberg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2012</study_first_submitted>
  <study_first_submitted_qc>June 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2012</study_first_posted>
  <last_update_submitted>January 8, 2013</last_update_submitted>
  <last_update_submitted_qc>January 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>AAstrup</investigator_full_name>
    <investigator_title>Head of Department</investigator_title>
  </responsible_party>
  <keyword>advanced glycation end products</keyword>
  <keyword>insulin sensitivity</keyword>
  <keyword>obesity</keyword>
  <keyword>inflammation</keyword>
  <keyword>metabolomics</keyword>
  <keyword>appetite</keyword>
  <keyword>CVD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

